Given previous reports37,38 that administering HDAC inhibitors to murine models of neurodevelopmental disorders can, in some cases, reverse ASD-like phenotypes, we tested the HDAC inhibitor SAHA/Vorinostat in our mouse model. This evidence concerns the gene HDAC9 and neurodevelopmental disorder.